Effects of Instrument Assisted Soft Tissue Mobilization on Healthy Tissue Regarding Range of Motion and Gait
Launched by BETH MARSCHNER · Sep 23, 2024
Trial Information
Current as of July 02, 2025
Completed
Keywords
ClinConnect Summary
No further information to note than what is described in the summary or elsewhere
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Individuals from a small regional university student body, faculty and staff may choose to volunteer to participate in this study.
- Exclusion Criteria:
- • Acute spinal cord injury with neurological deficits
- • Neurological disorders
- • Acute lower extremity injury such as sprain or strain
- • Acute lower extremity pain causing gait deviation
- • Any type of lower extremity fracture within the past 12 months
- • Lumbar disc pathology with radicular symptoms
- • Use of blood thinning or clotting medications
- • Known connective tissue disorder
About Beth Marschner
Beth Marschner is a dedicated clinical trial sponsor committed to advancing medical research and improving patient outcomes through innovative trial designs and rigorous methodologies. With a focus on ethical practices and collaboration, Marschner leads initiatives that bridge the gap between scientific discovery and clinical application. The organization emphasizes patient safety and data integrity while fostering partnerships with healthcare professionals and institutions. By prioritizing transparency and accountability, Beth Marschner aims to contribute significantly to the development of effective therapies and enhance the overall landscape of clinical research.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Minot, North Dakota, United States
Patients applied
Trial Officials
Beth Marschner, DPT
Principal Investigator
Minot State University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported